lobbying_filings_raw: fcd08a3e-73ed-4e97-8ead-7654d0b62839
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| fcd08a3e-73ed-4e97-8ead-7654d0b62839 | Q2 | 305932 | THE PETRIZZO GROUP, INC. | 204828 | ACCESS TO ADVANCED HEALTH INSTITUTE | 2021 | second_quarter | 2021-07-17T15:10:27.660000-04:00 | 50000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/fcd08a3e-73ed-4e97-8ead-7654d0b62839/", "filing_uuid": "fcd08a3e-73ed-4e97-8ead-7654d0b62839", "filing_type": "Q2", "filing_type_display": "2nd Quarter - Report", "filing_year": 2021, "filing_period": "second_quarter", "filing_period_display": "2nd Quarter (Apr 1 - June 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/fcd08a3e-73ed-4e97-8ead-7654d0b62839/print/", "filing_document_content_type": "text/html", "income": "50000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "T.J. Petrizzo, Chairman & CEO", "dt_posted": "2021-07-17T15:10:27.660000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "601 New Jersey Ave NW", "registrant_address_2": "Suite 830", "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20001", "registrant": {"id": 305932, "url": "https://lda.senate.gov/api/v1/registrants/305932/", "house_registrant_id": 38088, "name": "THE PETRIZZO GROUP, INC.", "description": "Government Relations and Strategic Communications Firm", "address_1": "601 New Jersey Avenue NW", "address_2": "Suite 830", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20001", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "T.J. PETRIZZO", "contact_telephone": "+1 202-365-4583", "dt_updated": "2026-01-10T16:22:46.380302-05:00"}, "client": {"id": 204828, "url": "https://lda.senate.gov/api/v1/clients/204828/", "client_id": 1005216, "name": "ACCESS TO ADVANCED HEALTH INSTITUTE", "general_description": "Comprehensive approach creating vaccines and therapies to combat infectious diseases", "client_government_entity": false, "client_self_select": null, "state": "WA", "state_display": "Washington", "country": "US", "country_display": "United States of America", "ppb_state": "WA", "ppb_state_display": "Washington", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2020-04-06"}, "lobbying_activities": [{"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "FY22 funding for COVID-19 vaccine and therapy development and manufacturing; support adjuvant inclusion in COVID-19 countermeasures.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 68503, "prefix": null, "prefix_display": null, "first_name": "MEGAN", "nickname": null, "middle_name": "CRISTINA", "last_name": "PEREZ BURKE", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Director, Congresswoman Cathy McMorris Rodgers", "new": false}, {"lobbyist": {"id": 3241, "prefix": null, "prefix_display": null, "first_name": "TJ", "nickname": null, "middle_name": null, "last_name": "PETRIZZO", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 25, "name": "Defense, Dept of (DOD)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MED", "general_issue_code_display": "Medical/Disease Research/Clinical Labs", "description": "Advocating for funding for COVID-19 vaccine and therapy development and manufacturing; funding for flue vaccine, support adjuvant inclusion in COVID-19 countermeasures.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 3241, "prefix": null, "prefix_display": null, "first_name": "TJ", "nickname": null, "middle_name": null, "last_name": "PETRIZZO", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 68503, "prefix": null, "prefix_display": null, "first_name": "MEGAN", "nickname": null, "middle_name": "CRISTINA", "last_name": "PEREZ BURKE", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Director, Congresswoman Cathy McMorris Rodgers", "new": false}], "government_entities": [{"id": 25, "name": "Defense, Dept of (DOD)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Advocating for funding for COVID-19 vaccine and therapy development and manufacturing; funding for flu vaccine; support adjuvant inclusion in COVID-19 countermeasures.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 3241, "prefix": null, "prefix_display": null, "first_name": "TJ", "nickname": null, "middle_name": null, "last_name": "PETRIZZO", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 68503, "prefix": null, "prefix_display": null, "first_name": "MEGAN", "nickname": null, "middle_name": "CRISTINA", "last_name": "PEREZ BURKE", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Director, Congresswoman Cathy McMorris Rodgers", "new": false}], "government_entities": [{"id": 25, "name": "Defense, Dept of (DOD)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | DC | US | 38088 | WA | WA | US | US | Comprehensive approach creating vaccines and therapies to combat infectious diseases | 0 | 0 | 1698593 | normalized_name_state | 0.9 |